Chemoimmunotherapy and carbon ion radiation for advanced lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial combines chemotherapy, immunotherapy, and a special type of radiation called carbon ion therapy to treat lung cancer that has not spread but cannot be removed with surgery. The goal is to see if this combination can shrink the tumor and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of lung cancer called non-small cell lung cancer that is locally advanced and cannot be removed with surgery.
- You have not received any previous treatment for your cancer.
- You do not have certain gene changes (EGFR, ALK, or ROS-1) in your tumor.
- You do not have active or past autoimmune or inflammatory disorders.
- You are generally healthy with no major organ problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to give radiation therapy (carbon ion boost) to people with advanced, inoperable lung cancer. The goal is to see if targeting the most aggressive parts of the tumor with a higher dose can improve outcomes.
This trial tests a new type of radiation (carbon ion) plus chemotherapy for thymic tumors that cannot be removed with surgery. It aims to see if this combination can effectively treat the cancer while protecting healthy organs.
This trial tests whether carbon ion radiation (high-energy targeted radiation) can control peripheral non-small cell lung cancer in people who are medically unable to have surgery. It may help shrink or stop tumor growth while limiting harm to nearby organs.
This trial tests a new combination of immunotherapy and chemotherapy before and after standard chemoradiation for patients with stage III lung cancer that cannot be surgically removed. The goal is to see if this approach improves outcomes compared to chemoradiation alone.
This trial tests giving chemotherapy, immunotherapy, and targeted radiation before surgery for people with non-small cell lung cancer that can be removed. The goal is to see if this combination shrinks tumors and improves outcomes.
This trial tests a new treatment that combines immunotherapy (drugs that help your immune system fight cancer) with carbon ion radiation (a precise type of radiation) for people with locally advanced cervical cancer that hasn't spread to other organs. The goal is to see if this combination is safe and effective.
Hear when a new Carbon Ion Radiotheray trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.